J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Foulds, G
Right arrow Articles by Weidler, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foulds, G
Right arrow Articles by Weidler, D.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Articles

Fluconazole penetration into cerebrospinal fluid in humans

G Foulds, DR Brennan, C Wajszczuk, A Catanzaro, DC Garg, W Knopf, M Rinaldi, and DJ Weidler

One hour after intravenous doses of 50 mg/d fluconazole for 6 days or 100 mg/d for seven days to healthy subjects, the cerebrospinal fluid concentrations of fluconazole were 1.26 mg/L and 2.74 mg/L, respectively. These values were approximately 52% and 62% those of serum. Four patients with an initial clinical diagnosis of meningitis also had significant concentrations of fluconazole in the cerebrospinal fluid.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Antimicrob. Agents Chemother.Home page
P. Kamberi, R. A. Sobel, K. V. Clemons, A. Waldvogel, J. M. Striebel, P. L. Williams, and D. A. Stevens
Comparison of Itraconazole and Fluconazole Treatments in a Murine Model of Coccidioidal Meningitis
Antimicrob. Agents Chemother., March 1, 2007; 51(3): 998 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
B. A. Boucher, S. R. King, H. L. Wandschneider, W. L. Hickerson, S. D. Hanes, V. L. Herring, T. W. Canada, and M. M. Hess
Fluconazole Pharmacokinetics in Burn Patients
Antimicrob. Agents Chemother., April 1, 1998; 42(4): 930 - 933.
[Abstract] [Full Text]

Home page
 Arch OphthalmolHome page
D. M. O'Day, W. S. Head, R. D. Robinson, T. E. Williams, and R. Wolff
Ocular Pharmacokinetics of Saperconazole in Rabbits: A Potential Agent Against Keratomycoses
Arch Ophthalmol, April 1, 1992; 110(4): 550 - 554.
[Abstract] [PDF]

Home page
 ANN INTERN MEDHome page
R. A. Larsen, M. A. E. Leal, and L. S. Chan
Fluconazole Compared with Amphotericin B plus Flucytosine for Cryptococcal Meningitis in AIDS: A Randomized Trial
Ann Intern Med, August 1, 1990; 113(3): 183 - 187.
[Abstract] [PDF]

Home page
 Arch OphthalmolHome page
D. M. O'Day, G. Foulds, T. E. Williams, R. D. Robinson, R. H. Allen, and W. S. Head
Ocular Uptake of Fluconazole Following Oral Administration
Arch Ophthalmol, July 1, 1990; 108(7): 1006 - 1008.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the American College of Clinical Pharmacology